 | • レポートコード：B-GIR09D3756 • 出版社/出版日：GlobalInfoResearch / 2019年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、日光角化症治療の世界市場について調べ、まとめました。種類別セグメントは、破壊的治療、光線力学療法、局所薬、その他等、用途別セグメントは、病院、クリニック、その他等に区分しました。日光角化症治療の世界市場概観、企業動向、企業別日光角化症治療シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・日光角化症治療の市場概観 ・日光角化症治療の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・日光角化症治療の企業別販売動向、市場シェア、市場集中度、競争動向 ・日光角化症治療の世界市場規模 ・日光角化症治療の北米市場分析（アメリカ、カナダ、メキシコ等） ・日光角化症治療のアメリカ市場規模推移 ・日光角化症治療のカナダ市場規模推移 ・日光角化症治療のメキシコ市場規模推移 ・日光角化症治療のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・日光角化症治療のドイツ市場規模推移 ・日光角化症治療のイギリス市場規模推移 ・日光角化症治療のロシア市場規模推移 ・日光角化症治療のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・日光角化症治療の日本市場規模推移 ・日光角化症治療の中国市場規模推移 ・日光角化症治療の韓国市場規模推移 ・日光角化症治療のインド市場規模推移 ・日光角化症治療の東南アジア市場規模推移 ・日光角化症治療の南米市場分析（ブラジル、アルゼンチン等） ・日光角化症治療の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・日光角化症治療の種類別分析/販売量、売上、市場シェア（破壊的治療、光線力学療法、局所薬、その他） ・日光角化症治療の用途別分析/市場規模（病院、クリニック、その他） ・日光角化症治療の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・日光角化症治療の販売チャネル・代理店・貿易業者・ディーラー分析 |
Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It’s most commonly found on the face, lips, ears, back of your hands, forearms, scalp or neck.
Scope of the Report:
The classification of Actinic Keratosis Treatment includes Destructive Treatment, Photodynamic Therapy, Topical Medications and Other, and the Most of Actinic Keratosis Treatment is Destructive Treatment, and proportion of Destructive Treatment in 2017 is about 81.4%. Cryotherapy was the most ordinarily looked for treatment by clinicians. Notwithstanding, better clinical consequences of photodynamic treatment and developing inclination for medications in view of medication gadget mix have asked both parental figures and patients to choose novel treatment techniques that offer both propelled adequacy, stylish advantages and decreased danger of future malignancies.
Actinic Keratosis Treatment is widely used in hospital, clinic and other. The most proportion of Actinic Keratosis Treatment is used in clinic, and the proportion in 2017 is about 63%.
Market competition is intense. DUSA Pharmaceuticals, Novartis, Perrigo, LEO Pharma, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers. The major company of Photodynamic Therapy for Actinic Keratosis Treatment is DUSA Pharmaceuticals, Galderma (Nestle), Biofrontera in USA.
The global Actinic Keratosis Treatment market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Actinic Keratosis Treatment.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Actinic Keratosis Treatment market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Actinic Keratosis Treatment market by product type and applications/end industries.
Market Segment by Companies, this report covers
DUSA Pharmaceuticals
Novartis
Perrigo
LEO Pharma
Bausch Health
Taro Pharmaceutical
Galderma (Nestle)
Biofrontera
Almirall
Tolmar Pharmaceutical
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Destructive Treatment
Photodynamic Therapy
Topical Medications
Other
Market Segment by Applications, can be divided into
Hospital
Clinic
Other
Table of Contents
1 Actinic Keratosis Treatment Market Overview
1.1 Product Overview and Scope of Actinic Keratosis Treatment
1.2 Classification of Actinic Keratosis Treatment by Types
1.2.1 Global Actinic Keratosis Treatment Revenue Comparison by Types (2019-2024)
1.2.2 Global Actinic Keratosis Treatment Revenue Market Share by Types in 2018
1.2.3 Destructive Treatment
1.2.4 Photodynamic Therapy
1.2.5 Topical Medications
1.2.6 Other
1.3 Global Actinic Keratosis Treatment Market by Application
1.3.1 Global Actinic Keratosis Treatment Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Actinic Keratosis Treatment Market by Regions
1.4.1 Global Actinic Keratosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Actinic Keratosis Treatment Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Actinic Keratosis Treatment Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Actinic Keratosis Treatment Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Actinic Keratosis Treatment Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Actinic Keratosis Treatment Status and Prospect (2014-2024)
1.5 Global Market Size of Actinic Keratosis Treatment (2014-2024)
2 Manufacturers Profiles
2.1 DUSA Pharmaceuticals
2.1.1 Business Overview
2.1.2 Actinic Keratosis Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Actinic Keratosis Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.3 Perrigo
2.3.1 Business Overview
2.3.2 Actinic Keratosis Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Perrigo Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.4 LEO Pharma
2.4.1 Business Overview
2.4.2 Actinic Keratosis Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 LEO Pharma Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.5 Bausch Health
2.5.1 Business Overview
2.5.2 Actinic Keratosis Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Bausch Health Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.6 Taro Pharmaceutical
2.6.1 Business Overview
2.6.2 Actinic Keratosis Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.7 Galderma (Nestle)
2.7.1 Business Overview
2.7.2 Actinic Keratosis Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Galderma (Nestle) Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.8 Biofrontera
2.8.1 Business Overview
2.8.2 Actinic Keratosis Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Biofrontera Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.9 Almirall
2.9.1 Business Overview
2.9.2 Actinic Keratosis Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Almirall Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
2.10 Tolmar Pharmaceutical
2.10.1 Business Overview
2.10.2 Actinic Keratosis Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
3 Global Actinic Keratosis Treatment Market Competition, by Players
3.1 Global Actinic Keratosis Treatment Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Actinic Keratosis Treatment Players Market Share
3.2.2 Top 10 Actinic Keratosis Treatment Players Market Share
3.3 Market Competition Trend
4 Global Actinic Keratosis Treatment Market Size by Regions
4.1 Global Actinic Keratosis Treatment Revenue and Market Share by Regions
4.2 North America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
4.3 Europe Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
4.5 South America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
5 North America Actinic Keratosis Treatment Revenue by Countries
5.1 North America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
5.2 USA Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
5.3 Canada Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
5.4 Mexico Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
6 Europe Actinic Keratosis Treatment Revenue by Countries
6.1 Europe Actinic Keratosis Treatment Revenue by Countries (2014-2019)
6.2 Germany Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
6.3 UK Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
6.4 France Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
6.5 Russia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
6.6 Italy Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Actinic Keratosis Treatment Revenue by Countries
7.1 Asia-Pacific Actinic Keratosis Treatment Revenue by Countries (2014-2019)
7.2 China Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
7.3 Japan Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
7.4 Korea Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
7.5 India Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
8 South America Actinic Keratosis Treatment Revenue by Countries
8.1 South America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
8.2 Brazil Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
8.3 Argentina Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
8.4 Colombia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Actinic Keratosis Treatment by Countries
9.1 Middle East and Africa Actinic Keratosis Treatment Revenue by Countries (2014-2019)
9.2 Saudi Arabia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
9.3 UAE Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
9.4 Egypt Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
9.5 Nigeria Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
9.6 South Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
10 Global Actinic Keratosis Treatment Market Segment by Type
10.1 Global Actinic Keratosis Treatment Revenue and Market Share by Type (2014-2019)
10.2 Global Actinic Keratosis Treatment Market Forecast by Type (2019-2024)
10.3 Destructive Treatment Revenue Growth Rate (2014-2024)
10.4 Photodynamic Therapy Revenue Growth Rate (2014-2024)
10.5 Topical Medications Revenue Growth Rate (2014-2024)
10.6 Other Revenue Growth Rate (2014-2024)
11 Global Actinic Keratosis Treatment Market Segment by Application
11.1 Global Actinic Keratosis Treatment Revenue Market Share by Application (2014-2019)
11.2 Actinic Keratosis Treatment Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Other Revenue Growth (2014-2019)
12 Global Actinic Keratosis Treatment Market Size Forecast (2019-2024)
12.1 Global Actinic Keratosis Treatment Market Size Forecast (2019-2024)
12.2 Global Actinic Keratosis Treatment Market Forecast by Regions (2019-2024)
12.3 North America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
12.4 Europe Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
12.6 South America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
Figure Actinic Keratosis Treatment Picture
Table Product Specifications of Actinic Keratosis Treatment
Table Global Actinic Keratosis Treatment and Revenue (Million USD) Market Split by Product Type
Figure Global Actinic Keratosis Treatment Revenue Market Share by Types in 2018
Figure Destructive Treatment Picture
Figure Photodynamic Therapy Picture
Figure Topical Medications Picture
Figure Other Picture
Table Global Actinic Keratosis Treatment Revenue (Million USD) by Application (2014-2024)
Figure Actinic Keratosis Treatment Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Other Picture
Table Global Market Actinic Keratosis Treatment Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (2014-2024)
Table DUSA Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table DUSA Pharmaceuticals Actinic Keratosis Treatment Type and Applications
Table DUSA Pharmaceuticals Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Actinic Keratosis Treatment Type and Applications
Table Novartis Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Perrigo Basic Information, Manufacturing Base and Competitors
Table Perrigo Actinic Keratosis Treatment Type and Applications
Table Perrigo Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table LEO Pharma Basic Information, Manufacturing Base and Competitors
Table LEO Pharma Actinic Keratosis Treatment Type and Applications
Table LEO Pharma Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Bausch Health Basic Information, Manufacturing Base and Competitors
Table Bausch Health Actinic Keratosis Treatment Type and Applications
Table Bausch Health Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Taro Pharmaceutical Actinic Keratosis Treatment Type and Applications
Table Taro Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Galderma (Nestle) Basic Information, Manufacturing Base and Competitors
Table Galderma (Nestle) Actinic Keratosis Treatment Type and Applications
Table Galderma (Nestle) Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Biofrontera Basic Information, Manufacturing Base and Competitors
Table Biofrontera Actinic Keratosis Treatment Type and Applications
Table Biofrontera Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Almirall Basic Information, Manufacturing Base and Competitors
Table Almirall Actinic Keratosis Treatment Type and Applications
Table Almirall Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Tolmar Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Tolmar Pharmaceutical Actinic Keratosis Treatment Type and Applications
Table Tolmar Pharmaceutical Actinic Keratosis Treatment Revenue, Gross Margin and Market Share (2017-2018)
Table Global Actinic Keratosis Treatment Revenue (Million USD) by Players (2014-2019)
Table Global Actinic Keratosis Treatment Revenue Share by Players (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Share by Players in 2017
Figure Global Actinic Keratosis Treatment Revenue Share by Players in 2018
Figure Global Top 5 Players Actinic Keratosis Treatment Revenue Market Share in 2018
Figure Global Top 10 Players Actinic Keratosis Treatment Revenue Market Share in 2018
Figure Global Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Actinic Keratosis Treatment Revenue (Million USD) by Regions (2014-2019)
Table Global Actinic Keratosis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Market Share by Regions (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Market Share by Regions in 2018
Figure North America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Europe Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure South America Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table North America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
Table North America Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure North America Actinic Keratosis Treatment Revenue Market Share by Countries in 2018
Figure USA Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Canada Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Mexico Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table Europe Actinic Keratosis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Europe Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Europe Actinic Keratosis Treatment Revenue Market Share by Countries in 2018
Figure Germany Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure UK Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure France Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Russia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Italy Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Actinic Keratosis Treatment Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Actinic Keratosis Treatment Revenue Market Share by Countries in 2018
Figure China Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Japan Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Korea Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure India Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table South America Actinic Keratosis Treatment Revenue by Countries (2014-2019)
Table South America Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure South America Actinic Keratosis Treatment Revenue Market Share by Countries in 2018
Figure Brazil Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Argentina Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Colombia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Actinic Keratosis Treatment Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Actinic Keratosis Treatment Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Actinic Keratosis Treatment Revenue Market Share by Countries in 2018
Figure Saudi Arabia Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure UAE Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Egypt Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure Nigeria Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Figure South Africa Actinic Keratosis Treatment Revenue and Growth Rate (2014-2019)
Table Global Actinic Keratosis Treatment Revenue (Million USD) by Type (2014-2019)
Table Global Actinic Keratosis Treatment Revenue Share by Type (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Share by Type (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Share by Type in 2019
Table Global Actinic Keratosis Treatment Revenue Forecast by Type (2019-2024)
Figure Global Actinic Keratosis Treatment Market Share Forecast by Type (2019-2024)
Figure Global Destructive Treatment Revenue Growth Rate (2014-2019)
Figure Global Photodynamic Therapy Revenue Growth Rate (2014-2019)
Figure Global Topical Medications Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Table Global Actinic Keratosis Treatment Revenue by Application (2014-2019)
Table Global Actinic Keratosis Treatment Revenue Share by Application (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Share by Application (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue Share by Application in 2019
Table Global Actinic Keratosis Treatment Revenue Forecast by Application (2019-2024)
Figure Global Actinic Keratosis Treatment Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Actinic Keratosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Actinic Keratosis Treatment Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Actinic Keratosis Treatment Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
Figure Europe Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
Figure South America Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Actinic Keratosis Treatment Revenue Market Forecast (2019-2024)
世界の光線角化症治療薬市場予測（～2024年） Actinic keratosis (AKs or solar keratoses) are keratotic macules, papules, or plaques resulting from the intraepidermal proliferation of atypical keratinocytes in response to prolonged exposure to ultraviolet radiation. It's most commonly found on the face, lips, ears, back of your hands, forearms, …- 世界の仙腸炎治療市場予測（～2024年） Sacroiliitis is a medical condition caused by any inflammation within one, or both, of the sacroiliac joints. Sacroiliitis is a feature of spondyloarthropathies, such as axial spondyloarthritis (including ankylosing spondylitis), psoriatic arthritis, reactive arthritis or arthritis related to inflam…
- 世界の腱炎治療市場予測（～2024年） Tendinitis is irritation or inflammation of a tendon, a thick cord that attaches muscle to bone. Tendinitis is also called tendonitis. Tendinitis mainly caused due to sudden injury or activities that put stress on the tendons. Scope of the Report: The global Tendinitis Treatment market is valued at …
- 世界の非外科的外側上顆炎治療市場予測（～2024年）：企業別、地域別、種類・用途別 The non surgical treatment includes extracorporeal shock wave therapy, braces, medications and physical therapies. Various anti inflammatory drugs (NSAIDS) such as ibuprofen, aspirin and cortisone are administered to control pain in lateral epicondylitis. Scope of the Report: The global Non-surgica…
- 世界の自動車表面処理/熱処理市場予測（～2024年）：企業別、地域別、種類・用途別 Heat treatment and surface modification are the key technologies available today, to enhance the effective use of materials, to achieve the desired properties of the components used in the automotive industries, to save energy and conserve natural resources. Scope of the Report: Heat treatment is a …